The cooperation between P-gp and molecules capable of inhibiting apoptosis-related proteins can generate a more robust drug resistance in cancer cells in general, and CML cells in particular. This evidence concerns the gene PGP and chronic myelogenous leukemia, BCR-ABL1 positive.